Mark Auerbach - Net Worth and Insider Trading

Mark Auerbach Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Mark Auerbach owns 5 companies in total, including Assembly Biosciences Inc (ASMB) , RCS Capital Corp (RCAPQ) , and Woodbrook Group Holdings Inc (WDBG) among others .

Click here to see the complete history of Mark Auerbach’s form 4 insider trades.

Insider Ownership Summary of Mark Auerbach

Ticker	Comapny	Transaction Date	Type of Owner
ASMB	Assembly Biosciences Inc	2010-12-15	director
RCAPQ	RCS Capital Corp	2015-12-18	director
WDBG	Woodbrook Group Holdings Inc	2008-06-24	director
		2008-06-04	director
		2021-12-23	director

Mark Auerbach Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Mark Auerbach Ownership Network

Ownership Network List of Mark Auerbach

No Data

Ownership Network Relation of Mark Auerbach

Mark Auerbach Owned Company Details

What does Assembly Biosciences Inc do?

Who are the key executives at Assembly Biosciences Inc?

Mark Auerbach is the director of Assembly Biosciences Inc. Other key executives at Assembly Biosciences Inc include 10 percent owner Alexander Schornstein , Chief Legal & Business Officer Jason A Okazaki , and Chief Manufacturing Officer Nicole S White .

Assembly Biosciences Inc (ASMB) Insider Trades Summary

Over the past 18 months, Mark Auerbach made no insider transaction in Assembly Biosciences Inc (ASMB). Other recent insider transactions involving Assembly Biosciences Inc (ASMB) include a net sale of 24,793 shares made by Jason A Okazaki , a net sale of 4,737 shares made by Nicole S White , and a net purchase of 1,064,080 shares made by Alexander Schornstein .

In summary, during the past 3 months, insiders sold 354 shares of Assembly Biosciences Inc (ASMB) in total and bought 10,000 shares, with a net purchase of 9,646 shares. During the past 18 months, 14,581 shares of Assembly Biosciences Inc (ASMB) were sold and 106,090 shares were bought by its insiders, resulting in a net purchase of 91,508 shares.

Assembly Biosciences Inc (ASMB)'s detailed insider trading history can be found in Insider Trading Tracker table.

Assembly Biosciences Inc Insider Transactions

No Available Data

What does RCS Capital Corp do?

Who are the key executives at RCS Capital Corp?

Mark Auerbach is the director of RCS Capital Corp. Other key executives at RCS Capital Corp include 10 percent owner Luxor Capital Group, Lp , 10 percent owner Lcg Holdings Llc , and 10 percent owner Luxor Capital Partners Offshore Ltd .

RCS Capital Corp (RCAPQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of RCS Capital Corp (RCAPQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of RCS Capital Corp (RCAPQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

RCS Capital Corp (RCAPQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

RCS Capital Corp Insider Transactions

No Available Data

What does Woodbrook Group Holdings Inc do?

Who are the key executives at Woodbrook Group Holdings Inc?

Mark Auerbach is the director of Woodbrook Group Holdings Inc. Other key executives at Woodbrook Group Holdings Inc include Chief Financial Officer David Jonathan Barrett , 10 percent owner Barry Rubenstein , and 10 percent owner Irwin Lieber .

Woodbrook Group Holdings Inc (WDBG) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Woodbrook Group Holdings Inc (WDBG) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Woodbrook Group Holdings Inc (WDBG) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Woodbrook Group Holdings Inc (WDBG)'s detailed insider trading history can be found in Insider Trading Tracker table.

Woodbrook Group Holdings Inc Insider Transactions

No Available Data

What does Rxelite Inc do?

Who are the key executives at Rxelite Inc?

Mark Auerbach is the director of Rxelite Inc. Other key executives at Rxelite Inc include and other: Former Officer and Director Andrew Uribe .

Rxelite Inc (RXEI) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Rxelite Inc (RXEI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Rxelite Inc (RXEI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Rxelite Inc (RXEI)'s detailed insider trading history can be found in Insider Trading Tracker table.

Rxelite Inc Insider Transactions

No Available Data

What does Pardes Biosciences Inc do?

Who are the key executives at Pardes Biosciences Inc?

Mark Auerbach is the director of Pardes Biosciences Inc. Other key executives at Pardes Biosciences Inc include 10 percent owner Fs Development Holdings Ii, Llc , 10 percent owner Foresite Capital Fund V, L.p. , and 10 percent owner Foresite Capital Opportunity Fund V, L.p. .

Pardes Biosciences Inc (PRDS) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Pardes Biosciences Inc (PRDS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Pardes Biosciences Inc (PRDS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Pardes Biosciences Inc (PRDS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Pardes Biosciences Inc Insider Transactions

No Available Data

Mark Auerbach Mailing Address

Above is the net worth, insider trading, and ownership report for Mark Auerbach. You might contact Mark Auerbach via mailing address: 1001 Santerre Drive, Grand Prairie Tx 75050.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.